News
The HHS wants to move oversight of the controversial drug discount program to the CMS, which has a more aggressive history ...
A federal judge ruled that the government did not violate the law in a dispute with J&J over the 340B drug discount program.
A federal court denied Johnson & Johnson's motion to implement a 340B drug rebate model, siding with HHS and hospitals who ...
From relentless claim denials and payer pressures to policy debates around prior authorization and the 340B program, this mid-year briefing unpacks the six essential stories every revenue cycle leader ...
Oklahoma lawmakers passed HB 2048 to protect the 340B Drug Pricing Program, overriding a veto amid growing pressure from pharmaceutical interests.
There are several ways the 340B program negatively impacts employers, according to Gremminger. One is that when a drug is filled through the 340B channel instead of through the employers’ PBM ...
Pharmalittle: We’re reading about a Moderna flu vaccine, a J&J loss over 340B rebate plans, and more
Moderna disclosed that a study of 56,000 volunteers older than 50 found its new mRNA flu vaccine was more effective than an ...
Johnson & Johnson failed to convince a federal judge that the US government acted unlawfully when it rejected the company’s ...
The U.S. District Court for the Middle District of Tennessee June 30 denied a motion for a preliminary injunction by AbbVie ...
The AHA June 27 filed an amicus brief in the U.S. District Court for the Middle District of Tennessee that defends the ...
The American Hospital Association and three other healthcare organizations have filed an amicus brief defending Tennessee’s 340B contract pharmacy law, which is facing a challenge from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results